ストックスクリーナーアプリを入手
1.23
6.03%
0.07
プレマーケット:
1.17
-0.06
-4.88%
Gelteq Ltd (GELS) 最新ニュース
GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
What's Going On With Gelteq Stock Friday?Gelteq (NASDAQ:GELS) - Benzinga
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - The Manila Times
Dogs accept gels that hide bitter medicine, Gelteq trials show - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
$Gelteq (GELS.US)$ 👍 sold all already. thank you![Drool][Cool Guy][Rich][Peace][Blessing] - Moomoo
Gelteq establishes Centre of Excellence in China to accelerate product development - BioSpectrum Asia
Gelteq establishes center of excellence in China’s Guangdong By Investing.com - Investing.com South Africa
Gelteq establishes center of excellence in China’s Guangdong - Investing.com
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - The Manila Times
Gelteq sets up Guangdong hub as China biotech deals near $60B - Stock Titan
Gelteq Limited announced that it expects to receive $3.5 million in funding - marketscreener.com
Gelteq (GELS) calls Special Meeting on convertible note share issuance and 9.99% cap - Stock Titan
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - MSN
GELS - Finviz
Gelteq secures up to $3.5 million in convertible debt financing By Investing.com - Investing.com India
Gelteq secures up to $3.5 million in convertible debt financing - Investing.com
Gelteq (NASDAQ: GELS) inks up to $3.5M structured convertible note deal - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Gelteq begins clinical trial for veterinary antiparasitic drug - Investing.com
Gelteq begins clinical trial for veterinary antiparasitic drug By Investing.com - Investing.com South Africa
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - The Manila Times
Inside Gelteq’s first vet drug trial in a $78B animal health market - Stock Titan
Gelteq secures up to $3.5M debt financing to support commercialization - MSN
Sommer Ray’s Imaraïs taps Healthy Extracts to make 4M beauty gummies - Stock Titan
TradingKey - TradingKey
Gelteq announces USD $3.5 million strategic debt financing to accelerate commercialization and support revenue growth - marketscreener.com
Gelteq Secures USD $3.5 Million in Debt Financing on May 12, 2026 - geneonline.com
Gelteq secures up to $3.5M debt financing for trials - Investing.com
Gelteq secures up to $3.5M debt financing for trials By Investing.com - Investing.com India
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - marketscreener.com
Gelteq lands $3.5M to speed its pharmaceutical and nutraceutical gels - Stock Titan
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - MSN
What makes Gelteq Limited (GELS) a compelling holding for the long term (Hovering) 2026-05-08Trending Entry Points - Newser
What Gelteq Limited (GELS) is doing that smarter investors notice (Institutional Selling) 2026-05-05Social Buzz - Newser
GELS Price Today: Gelteq Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
GELS (Gelteq Limited) management prioritizes emerging tech vertical investments to drive future sustainable revenue growth.Expert Momentum Signals - Newser
Simon H Szewach Net Worth (2026) - GuruFocus
Bradley Glenn Karp Net Worth (2026) - GuruFocus
Nathan J Givoni Net Worth (2026) - GuruFocus
Paul Michael Wynne Net Worth (2026) - GuruFocus
ETF Watch: Is Gelteq Limited likely to announce a buyback2026 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn
Market Review: How liquid is Gelteq Limited stockExit Point & Consistent Income Trade Recommendations - baoquankhu1.vn
What support levels matter for Gelteq Limited (GELS) Stock | Price at $0.75, Up 13.12%Trending Momentum Stocks - Newser
Gelteq Ltd (GELS) Cash Flow - TradingKey
Will Gelteq Limited (GELS) Stock Outperform Peers | Price at $0.70, Up 3.09%Stock Analysis Community - Newser
GELS PE Ratio & Valuation, Is GELS Overvalued - Intellectia AI
Five straight record quarters set up Healthy Extracts for a bigger 2026 - Stock Titan
Short Interest in Gelteq Limited Drops 26.3% in March - National Today
Travel Stocks: How does Gelteq Limited compare to its peers2026 Analyst Calls & Safe Capital Growth Stock Tips - baoquankhu1.vn
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound - MSN
Gelteq receives Nasdaq notice for minimum bid price deficiency By Investing.com - za.investing.com
Gelteq receives Nasdaq notice for minimum bid price deficiency - Investing.com
Nasdaq warns Gelteq (NASDAQ: GELS) after shares stay below $1.00 - Stock Titan
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26) - ChartMill
[Form 3] Gelteq Ltd Initial Statement of Beneficial Ownership - Stock Titan
Gelteq (NASDAQ: GELS) director reports family trust-held positions - Stock Titan
Gelteq Ltd (GELS) officer discloses 500,000 trust-held shares on Form 3 - Stock Titan
Gelteq Ltd (GELS) CEO details indirect share and note holdings - Stock Titan
GELS Earnings History & Surprises | EPS & Revenue Results | GELTEQ LTD (NASDAQ:GELS) - ChartMill
GELS Should I Buy - Intellectia AI
2.11%
大文字化:
|
ボリューム (24 時間):